ACTIVITY DESCRIPTION / STATEMENT OF NEED:
The syndrome of right heart failure is poorly understood and defined. Clinicians often fail to diagnose early stages of the disease and allow the manifestations to progress to severe disability. There is a pressing need to define, understand, and inculcate awareness about this disease in clinicians. Similarly, understanding right heart dysfunction requires focused investigations and research study, best brought forth by a multidisciplinary collaboration. This program is intended for clinical and research professionals who are involved in the care of patients with, and the study of, right heart disease, congenital heart disease, pulmonary hypertension, and associated disorders.
The content of this internet enduring material activity was originally presented as part of a live event. It is divided into three different learning activities, each with multiple videos. For each of the three activities, learners must view all videos in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit.
This program has been designed for physicians, pharmacists, hospitalists, surgeons, nurses, nurse practitioners, physician assistants, and allied healthcare professionals in the fields of cardiology, pulmonology, critical care medicine, emergency medicine, rheumatology, internal medicine, and vascular medicine.
By the end of the session the participant will be able to:
- Describe the unique structure and function of the right ventricle (RV) with a focus on anatomical and embryological differences between the RV and LV
- Discuss the importance of RV and pulmonary arterial coupling and its role in RV function and RV failure
- Summarize the emerging role of advanced imaging in assessing RV function
- Evaluate the current data regarding myocardial metabolism and RV function
- Given a patient case, formulate a management approach that takes into account RV structure, function, and maladaptation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of ScientiaCME and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
Physicians: ScientiaCME designates these internet enduring material activities for a maximum of 13 AMA PRA Category 1 Credit(s)™ toward the AMA Physician’s Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.
Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Pharmacists: ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. ScientiaCME designates the following CTEPH modules for a maximum of 13 contact hour(s) (1.30 CEUs). Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire group of presentations and complete the course evaluation to receive continuing pharmacy education credit. The modules are listed as follows:
- 5th Right Heart Symposium, Part 1: 0574-9999-22-013-H01-P: 2.25 contact hours (0.225 CEUs)
- 5th Right Heart Symposium, Part 2: 0574-9999-22-014-H01-P: 3.25 contact hours (0.325 CEUs)
- 5th Right Heart Symposium, Part 3: 0574-9999-22-015-H01-P: 3.75 contact hours (0.375 CEUs)
- 5th Right Heart Symposium, Part 4: 0574-9999-22-016-H01-P: 3.75 contact hours (0.375 CEUs)
This is an Knowledge (K)-type activity.
You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner’s responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.
The CPE statements of credit contain information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Supported by educational grants from Acceleron, Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, and United Therapeutics. This internet enduring material activity is part of a series of activities.
Participation in these activities is $99.00.
RELEASE DATE: May 4, 2022 — EXPIRATION DATE: May 3, 2023
The 5th Right Heart Symposium, Part 1
|VIDEO 1: Right Ventricular Structure Function Relationship|
|Right Ventricular Contraction and Contractility|
Tammo Delhaas, MD, PhD – Maastricht University
The Tricuspid Valve: The Foundation of Coupling
Andrew Peacock, Phil, MD, FRCP – University of Glasgow
|VIDEO 2: Right Ventricular Structure Function Relationship|
|Tricuspid Valve Dysfunction: Current State of the Art and Future Prospects |
Rebecca T. Hahn, MD, FACC, FASE – Columbia University
Tricuspid Regurgitation: Consequences with a Price
Elizabeth Gay, MD – Harvard Medical School
5th Right Heart Symposium, Part 2
|VIDEO 3: Assessment of the Right Heart: Integrative Approaches to Uncovering Right Heart Function|
|Dynamic Assessment of Right Ventricle-Pulmonary Artery Coupling: Application of Invasive CPET|
David M. Systrom, MD – Harvard Medical School
Right Ventricular Load and Function: Assessing the Impact of Left Heart Function on the Right Side
Luke Howard, MA, Phil, FRCP – National Heart & Lung Institute, Imperial College London
|VIDEO 4: Assessment of the Right Heart: Integrative Approaches to Uncovering Right Heart Function|
|Imaging Approaches to the Right Heart: Echo vs. cMR|
Anne Marie Valente, MD – Harvard Medical School
Assessing RV Remodeling with PET in Patients with Pulmonary Hypertension
Marcelo Fernando Di Carli, MD – Harvard Medical School
|VIDEO 5: Keynote Lecture|
|The Complex Relationship of the Right and Left Ventricle and Meaning of Ventricular Independence|
Mandeep R. Mehra, MD, MSc, FRCP – Harvard Medical School
5th Right Heart Symposium, Part 3
|VIDEO 6: Pulmonary Heart Disease and Remodeling|
|How Does Pulmonary Disease Drive Pulmonary Vascular and Myocardial Remodeling?|
Paul Hassoun, MD – The Johns Hopkins University
How Does Left Heart Disease Drive Pulmonary Vascular and Right Ventricular Remodeling?
Stephan Rosenkranz, MD – University of Cologne
How Does Congenital Heart Disease Drive Pulmonary Vascular Remodeling?
Mary Mullen, MD, PhD – Harvard Medical School
|VIDEO 7: Pulmonary Heart Disease and Remodeling|
|Right Heart Disease in the Absence of Pulmonary or Left Heart Disease|
Michael M. Givertz, MD – Harvard Medical School
Molecular Phenotyping of the Right Heart System: Is the Fog Starting to Clear?
Jane Leopold, MD, FACC, FAHA, FSCAI – Harvard Medical School
|VIDEO 8: Interventional Approaches to the Failing Right Heart|
|ECMO as a Bridge|
Paul Heerdt, MD – Yale School of Medicine, New Haven, C
Chronic Thromboembolic Pulmonary Hypertension: Surgical, Medical, and Interventional Options for Treatment
Piotr Sobieszczyk, MD – Harvard Medical School
Percutaneous Approaches to RV Support Now and in the Future
Steven P. Keller, MD – Johns Hopkins Medicine
5th Right Heart Symposium, Part 4
|VIDEO 9: Venous Thromboembolism|
|Submassive PE: What is it Really and What is the Best Approach to Treatment?|
Gregory Piazza, MD, MS – Harvard Medical School
Acute PE and Impact on RV
Yolanda Bryce, MD – Weill Medical College of Cornell University
Massive and Catastrophic PE: Strategies for Circulatory Support Both Pharmacologically and Mechanically
David M. Dudzinski, MD, FAHA, FACC, FASE – Harvard Medical School
|VIDEO 10: Keynote Lecture|
|Effects of Exercise Training on the Right Heart|
Mary Beth Brown, PT, PhD – University of Washington
|VIDEO 11: Critical Care and the Failing Right Heart|
|Drips to Machines – Supporting the Failing RH|
Evelyn M. Horn, MD – Weill Cornell Medical College of Cornell University
Physiologic Impact of Mechanical Ventilation on the Right Heart
Inderjit Singh, MD – Yale University
FACULTY DISCLOSURES AND RESOLUTION OF COI
Aaron Waxman, MD, PhD: Researcher, United Therapeutics
Andrew Peacock, Phil, MD: Advisory Board – Ferrer
Bradley A. Maron, MD: Steering Committee Member – Actelion; Investigator – Sponsored Research, Deerfield Corporation
Bradley Wertheim: Consultant – Change Healthcare
Evelyn Horn, MD: Data Safety Monitoring Board – AADi, SoniVie; Clinical Endpoint Committee – V-wave, Ltd.
Gregory Piazza, MD, MS: Research Grant – BMS/Pfizer, Janssen, Bayer, Portola, Amgen, Boston Scientific
Jane A Leopold, MD: Research Funding – Aria CV, Astellas, Inc.; Consultant – Abbott Vascular; Speaker – United Therapeutics
Luke Howard, MA, Phil: Advisor – Janssen, MSD, Bayer, Gossamer Bio; Speaker – Janssen, MSD, Bayer; Research Grants – Janssen
Mandeep R. Mehra, MD: Consultant – Abbott, Bayer, Portola, Mesoblast, NuPulse, Medtronic, FineHeart, Janssen, Triple Gene, Roivant, Baim Institute for Clinical Research, Leviticus
Marcelo F. Di Carli, MD: Research Grant – Gilead Sciences, Spectrum Dynamics
Paul Hassoun, MD: Consultant – MS&D
Paul Heerdt, MD: Consultant – Philips, BaudaxBio, Baxter
Phillip Joseph, MD: Consultant – United Therapeutics
Rebecca Hahn, MD: Consultant – Abbott Vascular, Boston Scientific Corp., Edwards Lifescience, Medtronic
Stephan Rosenkranz, MD: Consultant – Abbott, Acceleron, Actelion, Bayer, Janssen, MSD, Novartis, United Therapeutics, Vifor; Research Grants – Actelion, AstraZeneca, Bayer, Novartis, Janssen; Speaker – Actelion, Bayer, BMS, Ferrer, Janssen, MSD, Novartis, Pfizer, United Therapeutics, Vifor
Steven Keller, MD: Consultant – Abiomed, Inc., X-COR Therapeutics, Inc., CBSET, Inc.; Advisor – Paragonix Technologies
Individuals with no conflicts of interest to disclose:
- Content reviewer: Charles J Turck, PharmD, BCPS, BCCCP, President, ScientiaCME
- Anne Marie Valente, MD
- David Dudzinski, MD
- David Systrom, MD
- Eileen Harder, MD
- Elizabeth Gay, MD
- Inderjit Singh, MD
- Katharine Clapham, MD
- Mary Beth Brown, PT, PhD
- Mary Mullen, MD, PhD
- Michael Givertz, MD
- Piotr Sobieszczyk, MD
- Tammo Delhaas, MD
- Yolanda Bryce, MD
- Read the learning objectives above.
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Take the post-test.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
- Windows 7 or above
- Internet Explorer 8
- *Adobe Acrobat Reader
- Safari or Chrome or Firefox
- *Adobe Acrobat Reader
- Internet Explorer is not supported on Macintosh
*Required to view Printable PDF Version